Jordan Smith
About Jordan Smith
Jordan Smith is a Research Associate II at Asklepios BioPharmaceutical, Inc. in Durham, North Carolina, specializing in assay development and qualification with expertise in various molecular biology techniques.
Work at Asklepios BioPharmaceutical
Jordan Smith has been employed at Asklepios BioPharmaceutical, Inc. (AskBio) as a Research Associate II since 2020. In this role, Smith has contributed to the development of adeno-associated virus (AAV) methodologies, enhancing the company's research capabilities. Based in Durham, North Carolina, Smith's work focuses on advancing the understanding and application of AAV in therapeutic contexts.
Previous Experience at LabCorp Diagnostic Laboratories
Prior to joining AskBio, Jordan Smith worked as a Lab Technologist at LabCorp Diagnostic Laboratories from 2018 to 2020. During this two-year tenure, Smith specialized in immunology, gaining valuable experience in laboratory techniques and diagnostics. This role provided a foundation for Smith's subsequent transition to molecular biology in analytical development.
Education and Expertise
Jordan Smith earned a Bachelor of Science degree in Molecular Biology from Radford University, completing the program from 2014 to 2018. This educational background has equipped Smith with a strong foundation in biological sciences, particularly in assay development and qualification. Smith possesses expertise in quantitative PCR (qPCR), digital droplet PCR (ddPCR), and high-contrast DNA (HCDNA) assays.
Specialization in Assay Development
Jordan Smith specializes in assay development and qualification, focusing on molecular biology applications. Smith's expertise includes advanced techniques such as qPCR, ddPCR, and HCDNA assays. This specialization is integral to Smith's role at AskBio, where the development of reliable and accurate assays is critical for research and therapeutic applications.
Career Transition from Immunology to Molecular Biology
Jordan Smith transitioned from a focus on immunology at LabCorp to a specialization in molecular biology at Asklepios BioPharmaceutical. This shift reflects a strategic career development path, allowing Smith to apply immunological knowledge within the context of molecular biology and analytical development, enhancing research outcomes in gene therapy.